CAH - Cardinal Health, Inc.
51.75 0.00 (0.00%)
After hours: 5:46PM EDT
| Previous Close | 51.90 |
| Open | 51.84 |
| Bid | 50.13 x 2200 |
| Ask | 0.00 x 1000 |
| Day's Range | 51.19 - 52.10 |
| 52 Week Range | 48.14 - 75.75 |
| Volume | 3,605,756 |
| Avg. Volume | 3,481,700 |
| Market Cap | 16.078B |
| Beta | 1.12 |
| PE Ratio (TTM) | 63.89 |
| EPS (TTM) | 0.81 |
| Earnings Date | Nov 5, 2018 - Nov 9, 2018 |
| Forward Dividend & Yield | 1.91 (3.67%) |
| Ex-Dividend Date | 2018-09-28 |
| 1y Target Est | 54.40 |
- American City Business Journals•8 hours ago
St. Charles County lawsuit accuses drug companies, distributors of worsening opioid epidemic
St. Charles County has filed a lawsuit against a group of pharmaceutical manufacturers and drug distributors, accusing them of "aggressive and fraudulent marketing" of prescription opioid painkillers that has led to a drug abuse epidemic.
- Zacks•4 days ago
Cardinal Health Product Spectrum Broad, Competition Rife
Cardinal Health's (CAH) strategic buyouts lend it a competitive edge; the Cordis unit lacks luster.
- Reuters•6 days ago
Express Scripts staking out million-dollar gene therapies
Now it is quietly building a side business: getting paid to help drug companies dispense a new generation of high-priced drugs. Express Scripts is in talks with biotechnology companies Biomarin Pharmaceutical Inc (BMRN.O), Spark Therapeutics Inc (ONCE.O) and Bluebird Bio Inc (BLUE.O) to have its specialty pharmaceutical business exclusively distribute their new haemophilia therapies when they are expected to become available in 2019 and 2020, Chief Medical Officer Steve Miller told Reuters in an interview.
- GlobeNewswire•7 days ago
Recent Analysis Shows Automatic Data Processing, Denbury Resources, ITT, Cardinal Health, Geron, and The Hackett Group Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, Aug. 14, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Automatic ...
- PR Newswire•12 days ago
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio , Aug. 8, 2018 /PRNewswire/ -- The Cardinal Health (NYSE: CAH) board of directors today approved a quarterly dividend of $0.4763 per share. The dividend will be payable on October 15, 2018 to ...
Markit•13 days agoSee what the IHS Markit Score report has to say about Cardinal Health Inc.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Services sector is rising.
- InvestorPlace•13 days ago
3 Value Plays That Won’t Cut Investors
Nearly 10 years into the bull market, it’s getting progressively more difficult to find value in stocks. There are still good deals to be found, but value investors face the ever-present danger of trying to “catch a falling knife” and being cut as the shares fall further. #-ad_banner-#Learning how to catch the temporary discounts while avoiding the stocks with farther to fall comes down to finding the companies with the financial flexibility and strength to survive.
- Thomson Reuters StreetEvents•14 days ago
Edited Transcript of CAH earnings conference call or presentation 6-Aug-18 12:30pm GMT
Q4 2018 Cardinal Health Inc Earnings Call
- Investing.com•14 days ago
Stocks - Berkshire Hathaway, PepsiCo Rise in Pre-market; SeaWorld Soars
Investing.com - Stocks in focus in pre-market trade Monday:
Motley Fool•14 days agoCardinal Health, Inc. (CAH) Q4 2018 Earnings Conference Call Transcript
CAH earnings call for the period ending June 30, 2018.
- MarketWatch•14 days ago
Cardinal Health stock rises after Q4 profit, revenue beats
MARKET PULSE Cardinal Health Inc. (CAH) shares rose 1.5% in heavy Monday morning trade after the company reported fourth-quarter profit and revenue beats. The company reported a loss of $1.2 billion, or a loss of $3.
- Zacks•15 days ago
Cardinal Health (CAH) Surpasses Earnings Estimates in Q4
Cardinal Health (CAH) witnesses strong Q4, owing to strong sales at Pharmaceutical and the Medical segments. It provides an impressive FY19 view.
- Zacks•15 days ago
Cardinal Health (CAH) Q4 Earnings and Revenues Surpass Estimates
Cardinal (CAH) delivered earnings and revenue surprises of 8.60% and 2.32%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
- Investing.com•15 days ago
Top 5 Things To Know In The Market On Monday
Investing.com - Here are the top five things you need to know in financial markets on Monday, August 6:
- CNBC•15 days ago
Stocks making the biggest moves premarket: PEP, BRKB, CAH, TSN, PX & more
Indra Nooyi will step down as CEO of the snack and beverage giant on October 3 after 12 years, replaced by President Ramon Laguarta. Berkshire Hathaway BRK.A – Berkshire reported quarterly profit of $4190.13 per "A" share , beating the consensus estimate of $3386.62, while revenue also topped estimates. Warren Buffett's firm saw profits jump 67 percent from a year earlier, helped in part by a rebound in Berkshire's insurance business.
- Associated Press•15 days ago
Cardinal: Fiscal 4Q Earnings Snapshot
On a per-share basis, the Dublin, Ohio-based company said it had a loss of $3.76. Earnings, adjusted for one-time gains and costs, were $1.01 per share. The results topped Wall Street expectations. The ...
- Reuters•15 days ago
Drug distributor Cardinal's profit beats on pharma unit strength
U.S. drug distributor Cardinal Health Inc beat analyst estimates for adjusted fourth-quarter profit on Monday, supported by higher sales in its pharmaceutical and medical devices businesses. The company has been plagued with issues at its Cordis medical device unit, which it bought for $1.9 billion in 2015 from Johnson & Johnson. The company had missed quarterly profit expectations in May due to inventory and cost issues at the unit.
- Reuters•15 days ago
Cardinal Health posts fourth-quarter loss
Cardinal Health Inc reported a fourth-quarter loss compared to a year-ago profit, as the U.S. drug distributor was hit by an asset-impairment charge of $1.35 billion. Net loss attributable to the company ...
- PR Newswire•15 days ago
Cardinal Health Reports Fourth-quarter and Year-end Results for Fiscal Year 2018
- Fourth-quarter revenue increased 7 percent to $35 billion ; full-year revenue increased 5 percent to $137 billion - Full-year GAAP(1) operating earnings were $126 million and non-GAAP operating earnings ...
- Zacks•17 days ago
Medical Product Stock Earnings on Aug 6: CAH, HSIC & More
The Medical product market gains momentum owing to the recent two-year suspension of the controversial 2.3% Medical Device tax.
- American City Business Journals•18 days ago
Missouri governments sue drug companies over opioid epidemic
Ten Missouri counties and one city filed suit Wednesday against 49 companies, accusing them of worsening the opioid epidemic by misbranding drugs, among other things. The 274-page lawsuit, filed in St. Louis Circuit Court, seeks damages on behalf of the plaintiffs and their residents. The plaintiffs are Jefferson, Cape Girardeau, Christian, Crawford, Greene, Iron, Jasper, Stone, Taney, and Washington counties, and the city of Joplin.
Markit•19 days agoSee what the IHS Markit Score report has to say about Cardinal Health Inc.
Cardinal Health Inc NYSE:CAH
- Zacks•20 days ago
3 Dental Stocks to Top Earnings Estimates This Season
On upbeat consumer sentiment and increased business investments, the dental supplies industry appears to be in the pink of health now.
- Zacks•26 days ago
Options Traders Expect Huge Moves in Cardinal Health (CAH) Stock
Cardinal Health (CAH) needs investors to pay close attention to the stock based on moves in the options market lately.
Markit•26 days agoSee what the IHS Markit Score report has to say about Cardinal Health Inc.
Cardinal Health Inc NYSE:CAH
